End Hep C SF is a multi-sector collective impact* initiative that utilizes evidence-based practices, community wisdom, and the creative leveraging of resources to work toward hepatitis C elimination in San Francisco. San Francisco has a history of innovative and ambitious public health efforts. End Hep C SF emerges from that history to tackle an epidemic that kills more Americans than the deaths from sixty other reportable infectious diseases, including HIV, pneumococcal disease, and tuberculosis, combined.
Vision Statement: End Hep C SF envisions a San Francisco where hepatitis C is no longer a public health threat, and hepatitis C related health inequities have been eliminated.
Mission Statement: To support all San Franciscans living with and at risk for hepatitis C to maximize their health and wellness. We achieve this through prevention, education, testing, treatment, and linkage to reduce morbidity and mortality related to hepatitis C.
We have based our work on beliefs that:
- All people living with hepatitis C deserve access to the most effective treatment.
- Everyone living with or at risk for hepatitis C should have equal access to prevention and care regardless of individual characteristics, including but not limited to race/ethnicity, insurance status, housing status, gender identity, sexual orientation, age, mental health status and substance use.
- Our work is most effective when people who have lived experience with hepatitis C are involved in all aspects of planning and implementation.
- It is imperative to draw on the wisdom of service providers, activists, people who use drugs, and others in the community who have been most impacted and engaged in the fight against hepatitis C over many years.
We are committed to working together to:
- Provide interventions that are evidence based, and continuously review our progress to determine areas where we need to improve, through the regular collection of and use of local data related to hepatitis C.
- End stigma about hepatitis C and people living with hepatitis C.
- Maximize the health and wellness of people who use drugs by treating them with respect, ensuring access to appropriate services, and empowering them to reduce harm and make choices to improve their health.
- Continue to invest in populations that have frequently been characterized as "difficult to engage," as we realize that these groups often have the greatest unmet need for services and support.
End Hep C SF is guided by a Steering Committee and four topic-specific work groups that recommend action steps to the Steering Committee. The Work Groups are comprised of individuals affected by HCV, healthcare and social service providers, community advocates, health department representatives, and other stakeholders.
The Steering Committee is comprised of people who have expertise around hepatitis C and share the vision of hepatitis C elimination. Members represent several organizations and practices in San Francisco that are on the forefront of hepatitis C testing, linkage, treatment, and advocacy.
Current members of the Steering Committee include:
|Katie Burk||MPH, SFDPH|
|Kelly Eagen||MD, SFDPH|
|Rena Fox||MD, UCSF, VA|
|Theresa Hughes||Hughes Health Care Disparities|
|Emalie Huriaux||MPH, Project Inform & CalHEP|
|Isaac Jackson||Community Member|
|Annie Luetkemeyer||MD, ZSFG, UCSF|
|Alfredta Nesbitt||Bayview Hunters Point Foundation|
|Kyriell Noon||Glide Foundation|
|Robin Roth||San Francisco Hepatitis C Task Force|
|Mandana Khalili||MD, UCSF|
|Norah Terrault||MD, UCSF|
|Rachel McLean||MPH, CDPH|
|Pauli Gray||SF Aids Foundation|
Work groups are open to the public. We welcome anyone with lived experience with hepatitis C, people who work on hepatitis C related issues professionally, and anyone who wants to learn more about hepatitis C. To learn more about the initiative or to get involved email Katie Burk. You can also download our Vision Statement and Sign-On Sheet.
Research and Surveillance
The Research and Surveillance work group is comprised of researchers and epidemiologists who work on studies and surveillance related to hepatitis C. This group is broaching the question of how to best combine resources and information to understand the hepatitis C burden in San Francisco and to measure the progress we make towards eliminating hepatitis C.
Testing and Linkage
The Testing and Linkage work group is comprised of people who work for agencies that offer community-based hepatitis C testing and linkage services. These groups address the issue of how to identify and support marginalized San Franciscans who are most at risk for hepatitis C, yet among the least likely to be connected to services.
The Treatment Access work group is largely comprised of clinicians, pharmacists, and other direct service staff. This group focuses on initiatives to improve access to hepatitis C treatments for San Franciscans who receive care in both the public and private sectors. Another large focus of this group includes innovative treatment delivery mechanisms for patients in substance use treatment facilities, shelters, and occupancy hotels.
Prevention of Infection and Reinfection
The Prevention of infection and reinfection group is comprised of direct service staff and clinicians representing syringe access and methadone programs as well as medical clinics. This group works on refining of hepatitis C prevention messaging and developing message dissemination strategies.
*Collective Impact is a framework to tackle deeply entrenched and complex social problems. It is an innovative and structured approach to making collaboration work across government, business, philanthropy, non-profit organizations and citizens to achieve significant and lasting social change.
Send us a message
- HepC 101